Here we used EC isolated from cancer specimens (tumor-EC) and show thattrypsinogen 4 is required for the migration of tumor-EC promoted by thetumor microenvironment, and exerts its pro-angiogenic action through the inhibition of the tissue factor pathway inhibitor-2 (TFPI-2). Here, TFPI2 is linked to neoplasm.